Australia, July 18 -- Australia based Roche Products Pty Ltd has secured contract from National Blood Authority for Procurement of Imported Plasma and Recombinant Products (IPRP) - Hemlibra (emicizumab). The value of the contract is worth 317,718,916.90 AUD.

Published by HT Digital Content Services with permission from Pivotal Sources....